Scripps Research Logo

News Release

Scripps Research Team Develops Cheap, Easy "Kitchen Chemistry" to Perform Formerly Complex Synthesis

The New Method May Revolutionize Synthesis of Natural Products and Therapeutic Drugs

LA JOLLA, CA – December 3, 2009 – A team at The Scripps Research Institute has made major strides in solving a problem that has been plaguing chemists for many years: how best to break carbon-hydrogen bonds and then to create new bonds to join molecules together. This problem is of great interest to the pharmaceutical industry, which currently relies on a method to accomplish this feat that is relatively inefficient and sometimes difficult to perform.

The research, led by Scripps Research Associate Professor Jin-Quan Yu, was published November 26, 2009, in Science Express, an advance, online edition of the prestigious journal Science.

"This paper is a big jump forward," said Yu. "Our reaction is as simple as something you'd do in the kitchen. There are many fewer steps than the conventional method. There's less waste. In addition, everything you need is inexpensive and off-the-shelf—including common table salt."

Because carbon-hydrogen bonds are simple and abundant in naturally occurring organic molecules and in commercially available drugs, they are ideal targets for chemists who want to design and manipulate molecules. An improvement to current methods for working with these bonds has the potential to revolutionize work done in academic and industrial laboratories around the world.

"This work has significantly enhanced the chemist's tool box with more versatile and more economic alternatives," said Michael Rogers, director of the Pharmacology, Physiology, and Biological Chemistry Division at the National Institutes of Health's National Institute of General Medical Sciences. "The new method will have important downstream consequences for the production of new drugs, spurring diversification of medicinal compounds and lowering costs."

Bread-and-Butter Technology

Currently, to forge carbon-carbon bonds in place of carbon-hydrogen bonds, chemists rely heavily on a method called "Mizoroki-Heck reaction."

In this reaction, chemists first must install a halide in the molecule of interest as a "handle," replacing the existing carbon-hydrogen bonds with carbon-halide bonds. The chemists then join these molecules with other molecules using a metal catalyst, and then remove the "halide handle."

"Once installed, the halide can stick like glue," explained Yu, "so you can join one halogenated molecule with another molecule readily with a metal catalyst. The halide technique is very powerful and many technologies use it, including for the creation of almost any drug. It's a bread-and-butter technology."

But, despite its widespread use, this technique has some downsides. First, there's the waste (both in terms of labor and energy as well as literal waste) of the steps of adding and removing the halide from the molecules. Then, perhaps even more problematic, installing the halide into a molecule of interest isn't always so easy.

"To install a halide, you have to install it at the right position," said Yu. "You can't install it just anywhere. Sometimes that is impossible or difficult, taking many, many steps."

So the question arose: Can chemists develop a new method to manipulate carbon-hydrogen bonds and join together molecules without the intermediate step of installing a halide?

The Search for a Better Way

Over the last several years, many laboratories around the world have taken up this challenge. Early research in this new area of study (including papers by Yu) showed that this goal was possible to achieve under specialized conditions. However, making the reaction economically feasible and practical for the average chemistry laboratory was an elusive goal—until now.

In the new Science Express paper, Yu and colleagues start with a simple and commonly used substrate, a derivative of acetic acid (which gives vinegar it's sour taste).

"This substrate is used daily in the pharmaceutical industry and in natural product synthesis," said Yu. "It's a major class."

The team then designed ligands (molecules that bind to a site on a metal catalyst) out of simple derivatives of amino acids (protein building blocks). Because of their specific shape, these ligands guide the metal to break a carbon-hydrogen bond at a particular position selectively, and carbon-carbon bond formation with another molecule then takes place.

To demonstrate the utility and versatility of the lab's technique, for the study the team synthesized several natural product core structures. These included a complex molecule, a polyketide aromatic, that is an essential component of many antibiotics.

"The Science paper is the first demonstration that we can actually take an acetic acid derivative and then make a very complex molecule," said Yu. "And yet in none of the steps do we use anything the layman cannot afford or take off the shelf. We call it 'layman chemistry.' We expect that this reaction and others grounded in this philosophy will find many uses."

In addition to Yu, who is a recent recipient of the prestigious Eli Lilly Grantee Award, authors of the paper are graduate students Dong-Hui Wang and Keary Engle, and postdoctoral fellow Bing-Feng Shi, all of Scripps Research.

The research was supported by Scripps Research, the National Institutes of Health, Amgen, and Eli Lilly, as well as by fellowships from the A.P. Sloan Foundation, the National Science Foundation, the Department of Defense, Scripps Research, and the Skaggs Oxford Scholarship Program.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Scripps Florida is located in Jupiter, Florida.                            

# # #

For information:
Office of Communications 
Tel: 858-784-8134
Fax: 858-784-8136